07/14/2025
3:12 PM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2025
3:25 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
6:41 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:42 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:50 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
11:31 AM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2025
8:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
6:28 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
3:35 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
3:40 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2025
10:44 AM | Capital World Investors (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for NAMS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. |
05/08/2025
3:28 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form ARS | |
05/08/2025
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
6:36 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
4:41 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
4:34 PM | Gulfo Adele M. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
4:36 PM | Gulfo Adele M. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
4:41 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
4:06 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
4:36 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:18 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:20 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:24 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:29 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
5:19 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
5:00 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
3:27 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:29 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
03/10/2025
3:52 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
03/06/2025
4:32 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:10 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:54 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:06 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/26/2025
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2025
4:24 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:42 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
4:00 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:25 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad) Michael Robinson has been at the forefront of the technology market for over 40 years.
Spotting some profitable trends in tech … well ahead of Wall Street.
Like when he called Nvidia at a mere 80 cents a share.
Or Bitcoin when it was trading for just $300.
Throughout his illustrious career …
Michael has given his followers almost 150 different chances to register triple-digit gains. Now he's identified his next potential winner. Click here to find out more. |
01/29/2025
4:16 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:09 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:52 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Somaiya Mayur Ian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
3:26 PM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
7:27 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:58 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:03 PM | Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:08 PM | McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:09 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
4:57 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:08 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:10 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:12 PM | JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:29 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/06/2025
4:57 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:48 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:51 PM | JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:53 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:54 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:56 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:25 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:35 PM | BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
12/17/2024
4:05 PM | Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:00 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
12/17/2024
9:28 AM | Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
12/16/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:28 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
5:33 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B5 | |
12/12/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:57 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-3MEF | |
12/10/2024
3:48 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B5 | |
12/10/2024
6:24 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
6:07 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:29 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
11/14/2024
4:46 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/06/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024
7:02 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 20-F/A | |
10/18/2024
3:51 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
4:01 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:23 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:12 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
4:22 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Google did what!?!? (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
08/23/2024
3:20 PM | AMGEN INC (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13G/A | |
08/22/2024
3:30 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
08/09/2024
4:21 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B5 | |
08/09/2024
4:23 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
4:24 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form POS AM | |
08/07/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
7:30 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
